The blood dialyzer market has seen considerable growth due to a variety of factors.
• In the past few years, the market size for blood dialyzers has seen substantial growth. It's projected to increase from $5.09 billion in 2024 to $5.39 billion in 2025, signaling a compound annual growth rate (CAGR) of 5.9%.
Factors contributing to this historic period of growth include an aging population, increased spending in healthcare, growth in the number of dialysis centers, greater awareness and early detection of kidney disorders, and an increased prevalence of diabetes globally.
The blood dialyzer market is expected to maintain its strong growth trajectory in upcoming years.
• Over the coming years, the blood dialyzer market size is anticipated to experience considerable growth, expanding to $6.75 billion in 2029 with a 5.8% compound annual growth rate (CAGR).
The expansion during the forecast period is due to the escalating usage of cellulose membranes in blood dialyzers, the increasing prevalence of chronic kidney disease, the growth of healthcare infrastructure, the heightened occurrence of diabetes, and an increased understanding of kidney disorders. Notable trends within this forecast period include advancements in technology, the use of high-flux dialyzers, home dialysis options, smart technology utilization, and pediatric dialyzers.
The rising occurrence of chronic kidney ailments is predicted to boost the expansion of the blood dialyzer market. Chronic kidney disease (CKD) refers to the gradual deterioration of kidney function over a period of time, often triggered by conditions like diabetes or hypertension, and if not properly managed, it can result in kidney failure. Factors like increasing incidents of chronic conditions such as diabetes and hypertension, coupled with an aging populace, are contributing to the escalating prevalence of kidney diseases. Blood dialyzers play a crucial role in dealing with CKD by aiding patients to sustain a higher quality of life through performing the filtration tasks that their impaired kidneys are unable to execute. For example, in December 2023, the Australian Bureau of Statistics, a government organization based in Australia, stated that chronic kidney disease (CKD) is a significant global health issue, affecting more than 10% of the global population, which equates to over 800 million individuals. In the US, nearly 35.5 million adults, equating to about 14% of the adult population, are grappling with kidney disease. Alarmingly, it is essential to inform 9 out of 10 people suffering from this condition about their diagnosis. Thus, the escalating prevalence of chronic kidney diseases is fueling the expansion of the blood dialyzer market.
The blood dialyzer market covered in this report is segmented –
1) By Type: Single Pump, Double Pump
2) By Product Type: Reusable, Disposable
3) By Dialysis Membrane Material: Cellulose Membranes, Synthetic Membranes
4) By End-User: Hospitals, Ambulatory Surgical Centers, Home Care Settings, Specialty Clinics
Subsegments:
1) By Single Pump: Standard Single Pump Dialyzers, High-Flux Single Pump Dialyzers, Low-Flux Single Pump Dialyzers
2) By Double Pump: Standard Double Pump Dialyzers, High-Flux Double Pump Dialyzers, Low-Flux Double Pump Dialyzers
Leading firms in the dialyzer market for blood treatment are concentrating their efforts on creating novel products like dialyzer reprocessors to facilitate the secure reutilization of dialyzers. Dialyzer reprocessors are used to sterilize and clean previously used dialyzers, enabling their safe reuse for future dialysis procedures. To illustrate, NephroPlus, a dialysis service supplier based in India, introduced the Renova, a comprehensively digitized dialyzer reprocessor, in September 2022. The distinctive attribute of this new dialyzer reprocessor from NephroPlus is its ability for remote troubleshooting and its feature of cloud-based storage. This state-of-the-art technology lets biomedical engineers remotely supervise the machine's functioning and effectively identify and rectify any issues concerning valves or operational parameters without the need for in-person involvement, thus greatly reducing maintenance efforts and expenses. Furthermore, the incorporation of cloud-based data storage signifies a significant progression in the way dialysis equipment is managed, improving the overall efficacy and affordability for patients battling end-stage renal disease (ESRD).
Major companies operating in the blood dialyzer market are:
• Medtronic plc
• Fresenius Medical Care AG & Co KGaA
• Asahi Kasei Medical Co. Ltd.
• Toray Industries Inc.
• Baxter International Inc.
• DaVita Healthcare Partners Inc.
• Nipro Corporation
• Shandong Weigao Group Medical Polymer Company Limited
• Nikkiso Co. Ltd.
• Lepu Medical Technology Co. Ltd.
• Nxstage Medical Inc.
• Jiangxi Sanxin Medtec Co. Ltd.
• Bain Medical Equipment Co. Ltd.
• Polymed Medical Devices
• SB-Kawasumi Laboratories Inc.
• Bioteque Corporation
• Farmasol
• Medica S.p.A.
• Browdove Healthcare Ltd.
• Allmed Medical Care Holding Limited
• JMS Co. Ltd.
• Jihua Medical Apparatus and Instruments Co. Ltd.
North America was the largest region in the blood dialyzer market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the blood dialyzer market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.